Equity Research Health Information Services

Should You Buy Zhongchao Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 0/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Zhongchao Inc. (ZCMD) registers a weak Quality of Company score of 1.6/10. At the current price of $0.74, our 13-model framework evaluates whether the stock's discount is sufficient to compensate for high fundamental risks.

The short answer: 0 of 0 CirclFi valuation models project upside for Zhongchao Inc. (ZCMD) at $0.74 — the models are evenly split, with a Quality Score of 1.6/10 and Value-Trap risk of 100/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • Models are split: 0 bullish vs 0 bearish
  • Quality Score: 1.6/10 — Very Weak — significant concerns
  • Value Trap Risk: 100/100 — High danger — likely trap
  • Fair Value Range: — – —

Bullish Models

0 / 0

Bearish Models

0 / 0

Quality Score

1.6 /10

Very Weak — significant concerns

Value Trap Risk

100 /100
High danger

High danger — likely trap

Model Consensus

0 /13
Active Models

Full institutional coverage

What Is the Investment Case for Zhongchao Inc. (ZCMD) in 2026?

What Is the Bull Case vs the Bear Case for Zhongchao Inc. (ZCMD)?

Bull case versus bear case for Zhongchao Inc. (ZCMD) at $0.74, derived from 0 active CirclFi valuation models on 2026-09-15.
Bull case Bear case
No active model projects meaningful upside for ZCMD at $0.74. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. No active model flags significant downside for ZCMD. The Value Trap score of 100/100 still argues for some caution.

How Does ZCMD Compare to Its Health Information Services Peers?

MNDR Mobile-health Networ
2.7
DOCS Doximity, Inc.
9.5
ESSI Eco Science Solution
3.9
HQY HealthEquity, Inc.
9.5
DOGP Dogecoin Cash, Inc.
4.0
VEEV Veeva Systems Inc.
9.3
CERT Certara, Inc.
7.6
HCAT Health Catalyst, Inc
6.3

Valuation data pages: MNDR · DOCS · ESSI · HQY · DOGP · VEEV · CERT · HCAT · BRGX

See full Health Information Services rankings →

Which Other Stocks Score Like ZCMD on Quality?

Closest companies to ZCMD’s Quality of Company score of 1.6/10, across all industries.

Which Health Information Services Screens Does ZCMD Appear In?

Why Do CirclFi’s 0 Models Disagree on ZCMD?

What Are the Biggest Risks of Buying ZCMD Stock?

Weak Fundamentals

QOC 1.6/10 signals below-average quality.

Value Trap Warning

VT score 100/100 — apparent discount may mask decay.

Macro/Sector Risk

Health Information Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ZCMD Data Page →

So Is Zhongchao Inc. (ZCMD) Worth Buying in 2026?

Zhongchao Inc. currently lacks sufficient model coverage for a definitive valuation conclusion. We recommend monitoring as additional SEC filing data becomes available.

These are quantitative model outputs, not investment recommendations. Zhongchao Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About ZCMD Stock?

Should I buy ZCMD stock right now?

Based on CirclFi's multi-model analysis, 0 of 0 models see upside for ZCMD at $0.74. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Zhongchao Inc.?

Key risks include: an elevated Value Trap score of 100/100, suggesting apparent undervaluation may mask deteriorating fundamentals; a below-average Quality Score of 1.6/10, indicating fundamental weakness; limited model coverage (0/13 active), reducing analytical confidence; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.

How does ZCMD compare to its competitors?

Among Health Information Services peers, ZCMD holds a Quality Score of 1.6/10. Comparable companies include MNDR (QOC 2.7), DOCS (QOC 9.5), ESSI (QOC 3.9). The relative ranking helps investors identify whether ZCMD offers better fundamental quality than alternatives in the same sector.

Is ZCMD a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ZCMD's Quality Score of 1.6/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy ZCMD at?

CirclFi does not provide target buy prices or price alerts. However, our 0 active models produce fair value estimates ranging from — to —. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ZCMD.

View ZCMD Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →